National Comprehensive Cancer Network



About NCCN

Colon/Rectal/Anal Cancers Panel - Disclosures as of 5/23/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Tanios Bekaii-Saab, MD

Enzon Pharmaceuticals;
Genentech, Inc.;
National Cancer Institute;
Array Biopharma;
Oncolytics;
Polaris;
Roche Laboratories, Inc.

Amgen Inc.;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

6/5/2012

Al B. Benson III, MD, FACP

Abbott Laboratories;
Amgen Inc.;
Bayer HealthCare;
Genentech, Inc.;
Alchemia;
gilead;
Infinity

Agendia BV;
Bayer HealthCare;
Daiichi- Sankyo Co.;
Eli Lilly and Company;
Genentech, Inc.;
Genomic Health, Inc.;
National Cancer Institute;
Precision Therapeutics, Inc.

None

None

8/31/2012

Emily Chan, MD, PhD

Abbott Laboratories;
Amgen Inc.;
Genentech, Inc.;
ImClone Systems Incorporated;
Merck & Co., Inc.;
Pfizer Inc.;
Roche Laboratories, Inc.

Amgen Inc.;
Bayer HealthCare;
Bristol-Myers Squibb Company

None

None

11/5/2012

Yi-Jen Chen, MD, PhD

None

None

None

None

5/16/2013

Michael A. Choti, MD, MBA

None

Bayer HealthCare;
Bristol-Myers Squibb Company;
Genentech, Inc.;
sanofi-aventis U.S.

None

None

2/12/2013

Harry S. Cooper, MD

None

None

None

None

11/25/2012

Paul F. Engstrom, MD, FACP

None

None

None

None

2/27/2013

Peter C. Enzinger, MD

None

None

None

None

4/4/2013

Moon Fenton, MD, PhD

None

None

None

None

10/12/2012

Deborah Freedman-Cass, PhD

None

None

None

None

3/7/2013

Charles S. Fuchs, MD, MPH

Amgen Inc.;
ImClone Systems Incorporated

Amgen Inc.;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Genomic Health, Inc.;
ImClone Systems Incorporated;
Infinity Pharmaceuticals;
Metamark Genetics;
Momenta Pharmaceuticals;
Pfizer Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

6/14/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Jean L. Grem, MD

None

Adherex Technologies Inc.

None

None

8/16/2012

Steven Hunt, MD

None

None

None

None

3/8/2013

Ahmed Kamel, MD

None

None

None

None

10/16/2012

Lucille A. Leong, MD

None

None

None

None

5/23/2013

Edward Lin, MD

Bayer HealthCare;
Bristol-Myers Squibb Company;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Schering-Plough Corporation

None

None

None

10/12/2012

Kilian Salerno May, MD

None

None

None

None

6/5/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Mary F. Mulcahy, MD

None

None

None

None

1/26/2012

Eric Rohren, MD, PhD

None

None

None

None

5/17/2013

David P. Ryan, MD

None

Human Genome Sciences, Inc.

None

None

11/3/2011

Leonard Saltz, MD

Amgen Inc.;
Bayer HealthCare;
Bristol-Myers Squibb Company;
CureTech Ltd.;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
OSI Pharmaceuticals, Inc.;
Astellis;
Biothera;
Immunomedex;
Pfizer Inc.;
Roche Laboratories, Inc.;
Synta Pharmaceuticals Corp.;
Taiho Parmaceuticals Co., Ltd.

Bayer HealthCare;
CureTech Ltd.;
Genentech, Inc.;
Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Taiho Parmaceuticals Co., Ltd.

None

None

8/27/2012

Sunil Sharma, MD

None

None

None

None

6/21/2011

David Shibata, MD

None

None

None

None

6/7/2012

John M. Skibber, MD

None

None

None

None

10/25/2012

William Small, MD

None

None

None

None

6/5/2012

Constantinos T. Sofocleous, MD, PhD, FSIR

National Cancer Institute;
Sirtex

Sirtex Medical Inc

None

None

6/5/2012

Alan P. Venook, MD

Amgen Inc.;
Bayer HealthCare;
Genentech, Inc.;
Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

Abbott Laboratories;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation

None

None

4/30/2012

Christopher G. Willett, MD

None

None

None

None

11/14/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved